IL273690A - Gingivitis vaccine and related preparations and methods of using it - Google Patents

Gingivitis vaccine and related preparations and methods of using it

Info

Publication number
IL273690A
IL273690A IL273690A IL27369020A IL273690A IL 273690 A IL273690 A IL 273690A IL 273690 A IL273690 A IL 273690A IL 27369020 A IL27369020 A IL 27369020A IL 273690 A IL273690 A IL 273690A
Authority
IL
Israel
Prior art keywords
related compositions
periodontitis
vaccine
periodontitis vaccine
compositions
Prior art date
Application number
IL273690A
Other languages
English (en)
Hebrew (he)
Original Assignee
Sutrovax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sutrovax Inc filed Critical Sutrovax Inc
Publication of IL273690A publication Critical patent/IL273690A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0216Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/543Mucosal route intranasal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IL273690A 2017-10-12 2020-03-29 Gingivitis vaccine and related preparations and methods of using it IL273690A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762571582P 2017-10-12 2017-10-12
PCT/US2018/055496 WO2019075260A1 (en) 2017-10-12 2018-10-11 VACCINE AGAINST PERIODONTITIS AND ASSOCIATED COMPOSITIONS AND METHOD OF USE

Publications (1)

Publication Number Publication Date
IL273690A true IL273690A (en) 2020-05-31

Family

ID=64110091

Family Applications (1)

Application Number Title Priority Date Filing Date
IL273690A IL273690A (en) 2017-10-12 2020-03-29 Gingivitis vaccine and related preparations and methods of using it

Country Status (14)

Country Link
US (3) US10835590B2 (enExample)
EP (1) EP3694547A1 (enExample)
JP (2) JP7258870B2 (enExample)
KR (2) KR102530966B1 (enExample)
CN (1) CN111225684A (enExample)
AU (1) AU2018347511A1 (enExample)
CA (1) CA3078630A1 (enExample)
EA (1) EA202090908A1 (enExample)
IL (1) IL273690A (enExample)
MA (1) MA50363A (enExample)
MX (1) MX2020003810A (enExample)
PH (1) PH12020550239A1 (enExample)
SG (1) SG11202003147XA (enExample)
WO (1) WO2019075260A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020003810A (es) * 2017-10-12 2020-08-13 Vaxcyte Inc Vacuna contra la periodontitis y composiciones relacionadas y metodos de uso.
WO2025019900A1 (en) * 2023-07-26 2025-01-30 Denteric Pty Ltd Chimeric protein vaccine
CN116751292B (zh) * 2023-07-31 2024-05-14 河南大学 牙龈卟啉单胞菌Mfa1单克隆抗体及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59128338A (ja) 1982-12-08 1984-07-24 Kitasato Inst:The 歯周炎予防用ワクチン及びその製法
ATE182336T1 (de) 1993-05-28 1999-08-15 Chiron Corp Peptidinhibitoren der urokinaserezeptor-aktivität
AUPN627595A0 (en) 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
AU742668B2 (en) 1996-03-22 2002-01-10 Morehouse School Of Medicine Immunogenic compositions comprising porphyromonas gingivalis peptides and methods
US6833262B1 (en) 1999-04-21 2004-12-21 University Of Georgia Research Foundation, Inc. Polypeptide having amidolytic activity for a serpin
AUPQ065299A0 (en) 1999-05-28 1999-06-24 University Of Sydney, The A method of prophylaxis and treatment and agents useful for same
AUPQ485999A0 (en) 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
US7378101B2 (en) 2001-12-21 2008-05-27 Pfizer, Inc. Vaccine for periodontal disease
GB0411150D0 (en) 2004-05-19 2004-06-23 Queen Mary & Westfield College Vaccine
BR112012002429A2 (pt) 2009-08-02 2016-11-08 Sanofi Pasteur Ltd polipeptídeos de porphyromonas gingivalis
AU2011214908A1 (en) 2010-02-12 2012-09-20 Sydney West Area Health Services (Swahs) Protein domains and uses therefor
US9040253B2 (en) 2010-04-14 2015-05-26 Sutro Biopharma, Inc. Method for enhancing recombinant protein production by cell-free protein expression system
CA2887355C (en) 2012-10-12 2023-03-07 Sutro Biopharma, Inc. Proteolytic inactivation of select proteins in bacterial extracts for improved expression
WO2017066719A2 (en) * 2015-10-14 2017-04-20 Research Institute At Nationwide Children's Hospital Hu specific interfering agents
MX2020003810A (es) 2017-10-12 2020-08-13 Vaxcyte Inc Vacuna contra la periodontitis y composiciones relacionadas y metodos de uso.

Also Published As

Publication number Publication date
US20210361756A1 (en) 2021-11-25
SG11202003147XA (en) 2020-05-28
PH12020550239A1 (en) 2021-02-15
JP2020536925A (ja) 2020-12-17
CA3078630A1 (en) 2019-04-18
EP3694547A1 (en) 2020-08-19
JP2023098935A (ja) 2023-07-11
BR112020006500A2 (pt) 2020-10-13
US20240226259A9 (en) 2024-07-11
EA202090908A1 (ru) 2020-10-29
MA50363A (fr) 2020-08-19
KR20200070302A (ko) 2020-06-17
US11701414B2 (en) 2023-07-18
US12121575B2 (en) 2024-10-22
CN111225684A (zh) 2020-06-02
JP7258870B2 (ja) 2023-04-17
WO2019075260A1 (en) 2019-04-18
KR102530966B1 (ko) 2023-05-15
AU2018347511A1 (en) 2020-05-21
US20240131134A1 (en) 2024-04-25
US10835590B2 (en) 2020-11-17
US20190192645A1 (en) 2019-06-27
MX2020003810A (es) 2020-08-13
AU2018347511A8 (en) 2020-06-11
KR20230066660A (ko) 2023-05-16

Similar Documents

Publication Publication Date Title
IL274276A (en) CASZ preparations and methods of use
GB2582100B (en) CAS12C Compositions and methods of use
IL263287A (en) Neoepitope vaccines and methods of using them
IL268970A (en) New preparations and methods
ZA201801511B (en) Flavonoid compositions and methods of use
HUE065174T2 (hu) HLA-alapú módszerek és készítmények, valamint azok felhasználása
ZA201906169B (en) Synthekine compositions and methods of use
GB201807325D0 (en) Compositions and methods
ZA202104969B (en) Compositions comprising 15-hepe and methods of using the same
EP3802553A4 (en) SILICON CONTAINING COMPOSITIONS AND THEIR USE
IL276135A (en) Preparations and methods of use
IL269590A (en) Methods and compositions for reducing immunogenicity
GB202201861D0 (en) Novel methods and compositions
ZA202004531B (en) Compositions containing thymohydroquinone and their method of preparation
ZA202100780B (en) Bismuth-thiol compositions and methods of use
IL250853A0 (en) Periodontal gel preparation and method of use
ZA202004533B (en) Skin-brightening compositions and methods
ZA202000502B (en) Cosmetic compositions and methods of use
GB201801566D0 (en) Methods and compositions for nanormulsion vaccine formulations
IL274563A (en) Methods of use and preparations containing dolaglutide
SG11201803284YA (en) Novel method of use and compositions
IL273690A (en) Gingivitis vaccine and related preparations and methods of using it
IL250852A0 (en) Periodontal preparation and method of use
EP3256094A4 (en) Dental compositions and methods of use
IL261794A (en) Preparations and methods for using them